Seres Therapeutics, Inc. (MCRB)
Market Closed
17 Jul, 20:00
$
5. 33
+0.15
+2.8958%
$
52.78M Market Cap
- P/E Ratio
- Div Yield
56,400 Volume
-0.99 Eps
$ 5.18
Previous Close 
Analysts:
Want to track MCRB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Seres Therapeutics, Inc. Analysts
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| MK Matthew Keller HC Wainwright & Co. | 3,238.34 | $22,830.31 | $17,648.96 | -$5,181.35 | -22.7% |
 John Newman Canaccord Genuity | - | - | - | - | - |
 Chris Shibutani Goldman Sachs | 77,174.69 | $590,756.46 | $420,602.05 | -$170,154.41 | -28.8% |
